Approval · Notice of Compliance 5564 · 2004
CO CAPTOPRIL: Notice of Compliance 5564
Issued October 12, 2004
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 5564
- Date
- October 12, 2004
- Company
- Cobalt Pharmaceuticals IncorporatedToronto, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Abbreviated New Drug Submission (ANDS)
- Submission class
- Admin
- Reason
- New manufacturer and product name
- Therapeutic class
- Angiotensin-converting enzyme inhibitor
- Canadian reference product
- CAPOTEN
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| CO CAPTOPRIL | 02259508 | — |
| CO CAPTOPRIL | 02259516 | — |
| CO CAPTOPRIL | 02259524 | — |
| CO CAPTOPRIL | 02259532 | — |